相关实验视频

Updated: Jun 27, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

设计,合成和生物评估新合成的胺含化合物作为生物活性抗癌剂

Dalal Nasser Binjawhar¹, Fawziah A Al-Salmi², Maha Ali Alghamdi³

¹Department of Chemistry, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.

|April 29, 2024

概括

一种新的化胺衍生物,化合物6显示出对肝癌细胞显著的抗增殖作用. 这种化合物还抑制EGFR并诱导亡,表明其作为抗瘤剂的潜力.

科学领域:

药用化学医学化学
有机合成有机合成
癌症生物学癌症生物学

背景情况:

肝细胞癌 (HCC) 仍然是一个重大的全球健康挑战.
开发用于HCC的新型,有效的治疗剂至关重要.
化有机化合物为药物开发提供了独特的特性.

研究的目的:

合成和描述新型的肉胺化衍生物.
评估这些化合物对HepG2肝癌细胞的细胞毒性和抗增殖活性.
研究最强大的衍生品的作用机制.

主要方法:

合成p-化胺衍生物.
使用HepG2细胞系进行细胞毒性测定.
用光谱和元素微分析进行表征.
流细胞计用于细胞循环分析.
用光激活细胞分类 (FACS) 进行细胞亡评估.
线粒体膜潜力 (MMP) 测试.

主要成果:

化合物6是一种伊米达龙衍生物,对HepG2细胞表现出强烈的抗增殖活性 (IC50 = 4.23μM).
化合物6表现出与帕拉蒂尼布相似的表皮生长因子受体 (EGFR) 抑制活性.
细胞周期分析显示,在用化合物6治疗的HepG2细胞中,G1阶段停止.
在FACS分析中,复合6治疗的细胞中,早期和晚期亡比率增加.
化合物6通过内在途径诱导了亡,由线粒体膜潜能降低所证明.

结论:

合成的N-(N-pyrimidin-2-ylbenzenesulphamoyl) imidazolone衍生物6是治疗HCC的有希望的候选者.
化合物6表现出多个向的作用,包括抗扩散,EGFR抑制和亡诱导.
对化合物6的进一步优化可能会导致针对肝细胞癌的新型抗瘤剂的开发.

更多相关视频

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...